Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]

Ashkenazi M, Sity S, Sarouk I, et al. J Asthma Allergy. 2018;11:101–107. On page 101, in the Conclusion section, the text “omlaizumb” should have been “omalizumab”. Read the original article. 

Bibliographic Details
Main Authors: Ashkenazi M, Sity S, Sarouk I, Bar Aluma BE, Dagan A, Bezalel Y, Bentur L, De Boeck K, Efrati O
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Journal of Asthma and Allergy
Online Access:https://www.dovepress.com/erratumomalizumab-in-allergic-bronchopulmonary-aspergillosis-in-p-peer-reviewed-article-JAA